STEM CELL THERAPY RESEARCH ARTICLES intra-v
Stem cell therapy, a groundbreaking field in medical research, holds immense promise for revolutionizing the treatment of various diseases and injuries. As we stand on the cusp of a new era in healthcare, it's crucial to examine the current state of stem cell therapy research — exploring recent advances, addressing challenges, and envisioning the future of this transformative field.
Research on Stem Cell Therapy for Parkinson’s Disease
The promise and potential of stem cells in Parkinson’s disease1: This article discusses the potential of stem cells in treating Parkinson’s disease. It mentions a clinical trial led by Neurosurgeon Viviane Tabar, who is injecting stem cells into the brains of people with Parkinson’s disease to restore dopamine levels1.
Radical new therapy for Parkinson’s will use stem cell transplants2: This article talks about a new treatment for Parkinson’s disease involving tissue transplants. The treatment uses lab-grown stem cells transformed into nerve cells to replace those destroyed by the disease2.
Research on Stem Cell Therapy for TYPE 2 DIABETES
Towards a stem-cell therapy for diabetes1: This article discusses the potential of stem cells in treating diabetes. It mentions the isolation of the first human embryonic stem cell (hESC) lines in 1998 and how it opened the possibility of stem cell therapies for a variety of conditions, including Type 1 diabetes1.
Stem cell-based therapy for type 2 diabetes shows promise2: This article reveals how a combination of stem cell transplantation and antidiabetic medication successfully treated mice with type 2 diabetes2.
Treatment of type 2 diabetes mellitus with stem cells and …3: This review details the latest progress and ongoing studies related to the amalgamation of stem cells and antidiabetic drugs3.
RESEARCH ON STEM CELL THERAPY FOR HEART CONDITIONS
Here are some of the latest research articles on stem cell therapy for heart conditions:
Stem cell–derived heart cells injected into first patient: The Japanese biotech firm Heartseed and Danish pharmaceutical company Novo Nordisk have announced successful dosing of the first patient with their investigational cell therapy for severe heart failure. The first-in-human LAPiS phase 1/2 dose-escalation study uses heart muscle cells differentiated in vitro from induced pluripotent stem cells (iPSCs). The cardiomyocytes are injected directly into the patient’s heart muscle during a coronary bypass operation1.
Repairing the heart with stem cells: A new treatment using stem cells—which have the potential to grow into a variety of heart cell types—could potentially repair and regenerate damaged heart tissue. In a study, researchers treated 17 heart attack patients with an infusion of stem cells taken from their own hearts. A year after the procedure, the amount of scar tissue had shrunk by about 50%2.
Stem Cell Therapy Boosts Quality of Life for People With Advanced Heart: Patients with advanced heart failure can benefit from stem cell therapy, a large, new clinical trial has found. Injections of stem cells programmed to heal damaged heart tissue wound up improving overall quality of life for heart failure patients4.